J. O'Brien (Cape Town, South Africa), J. Stolk (Leiden, The Netherlands)
Expression of P53 protein in bronchial epithelium of iranian mustard agent victims: a cohort study
M. Ghanei, S. Amiri, H. Akbari, A. Hosseini, F. Alaedini, J. Aslani, D. D. Haines, C. Giardina (Tehran, Islamic Republic Of Iran; Washington DC, Storrs, United States Of America)
|  |
HsCRP is associated with COPD and a faster decline in FEV1 - a multicentre epidemiological study
T. Gislason, I. S. Olafsdottir, B. Thjodleifsson, I. Olafsson, D. Gislason, R. Jogin, C. Janson (Reykjavik, Iceland; Tartu, Estonia; Uppsala, Sweden)
| |
Identifying systemic inflammatory markers in the Melbourne COPD exacerbation cohort
S. Bozinovski, A. Hutchinson, D. Smallwood, M. Thompson, J. Black, L. Irving, G. Anderson (Parkville, Australia)
| |
Feasibility study using shotgun sequencing for proteomic analysis of human bronchoalveolar lavage applying HPLC coupled with linear ion trap MS/MS
A. Plymoth, Z. Yang, C. G. Lofdahl, A. Ekberg-Jansson, M. Dahlback, T. E. Fehniger, G. Marko-Varga, W. S. Hancock (Lund, Gothenburg, Sweden; Boston, United States Of America)
| |
Heat shock protein (HSP) 72 polymorphism in COPD patients
V. Müller, K. Rusai, Z. Kováts, A. Szabó, G. Losonczy, P. Magyar (Budapest, Hungary)
| |
Health indicators and inflammation - a comparison of stable smoking and ex-smoking COPD patients
M. McLaughlin, D. Anderson, J. Barr, A. Deans, C. Poland, C. McGuinnes, E. Drost, K. Donaldson, W. MacNee (Edinburgh, United Kingdom)
| |
Polymorphisms in the p53 and p21 promoter are associated with susceptibility to COPD
Y. T. Wang, W. Chen, W. K. Tsai, J. C. Lee, S. C. Chen, Y. L. Tsai, C. M. Shih (Taichung, Taiwan, Province Of China)
| |
Study of matrix metalloproteinase 1,9,12 polymorphisms and susceptibility to chronic obstructive pulmonary disease in Han nationality of North China
R. Zhang, Q. He, R. Yang, B. Lu (Beijing, China)
| |
Study about the association of genetic polymorphism of glutathione S-transferases and susceptibility to chronic obstructive pulmonary disease
R. Yang, Q. He, B. Lu, R. Zhang (Beijing, China)
| |
Phenotype of T cells in lung tissue from smokers with or without chronic obstructive pulmonary disease (COPD)
M. M. Marc, P. Korosec, I. Kern, M. Kosnik (Golnik, Slovenia)
| |
VDBP gene polymorphism in COPD
O. Baykara, S. Soyyigit, N. Buyru, T. Ulutin, M. Erk (Istanbul, Turkey)
| |
The link between systemic inflammation and pulmonary hypertension in patients with stable COPD
P. Joppa, R. Tkacova, D. Petrasova, B. Stancak, S. Misikova (Kosice, Slovakia)
| |
Does inflammation decrease after recovery from severe exacerbation of COPD?
J. Musil, M. Prucha (Prague, Czech Republic)
| |
Detection of RSV serotype A-B and adenovirus via PCR on samples from patients with COPD: exacerbation vs stable condition
N. Kokturk, S. Demirtas, G. Bozdayi, B. Dogan, S. Rota, T. Tatlicioglu (Ankara, Turkey)
| |
Myeloperoxidase in exhaled breath condensate reflects the status of lung parenchyma during the exacerbation of chronic obstructive pulmonary disease
N. Tateosian, C. Kehoe Wilson, P. C. Maffia, H. E. Chuluyan, J. A. Mazzei (Buenos Aires, Argentina)
| |
Increased concentration of matrix metalloproteinase-9 in serum of COPD patients
B. Brajer, B. Kuznar-Kaminska, A. Nowicka, H. Batura-Gabryel, A. Szczepanik (Pozna, Poland)
| |
Cellular profiles of induced sputum and bronchoalveolar lavage in patients with COPD
I. M. Lapteva, E. A. Lapteva, G. N. Tamashakina, L. K. Surkova, L. V. Lickevich (Minsk, Belarus)
| |
Involvement of nitric oxide, proinflammatory cytokines and effector cells in the inflammatory process in COPD patients
A. Chcialowski, W. Lubinski, T. Plusa, E. Pirozynska, W. Stankiewicz, I. Toczyska, R. Carewicz (Warsaw, Poland)
| |
Possible mechanisms of ventricular arrhythmias in patients with chronic obstructive pulmonary disease (COPD)
G. Ilonidis, E. Theofilogiannakos, G. Anogianakis, A. Anogeianaki, P. Tsekoura, P. Glouftsios (Thessaloniki, Greece)
| |